Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Common Equity (2016 - 2025)

Historic Common Equity for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $1.5 billion.

  • Merit Medical Systems' Common Equity rose 1556.6% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1556.6%. This contributed to the annual value of $1.4 billion for FY2024, which is 1475.53% up from last year.
  • Merit Medical Systems' Common Equity amounted to $1.5 billion in Q3 2025, which was up 1556.6% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Merit Medical Systems' Common Equity ranged from a high of $1.5 billion in Q3 2025 and a low of $976.7 million during Q1 2021
  • In the last 5 years, Merit Medical Systems' Common Equity had a median value of $1.2 billion in 2023 and averaged $1.2 billion.
  • In the last 5 years, Merit Medical Systems' Common Equity skyrocketed by 392.57% in 2021 and then skyrocketed by 1603.21% in 2025.
  • Merit Medical Systems' Common Equity (Quarter) stood at $1.0 billion in 2021, then grew by 10.06% to $1.1 billion in 2022, then grew by 5.03% to $1.2 billion in 2023, then grew by 14.76% to $1.4 billion in 2024, then increased by 10.88% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.4 billion during Q1 2025.